For patients whose diabetes is inadequately controlled on either Rybelsus or Januvia alone, several evidence-based alternative combinations are available that may offer superior glycaemic control and additional cardiometabolic benefits
PMID: 23524641
Ask about stability data for the specific sublingual formulation
To qualify for a prescription like Wegovy or Zepbound (tirzepatide), a service member or beneficiary generally must meet the following requirements: BMI Threshold: A body mass index (BMI) of 30 or higher (obesity), or a BMI of 27 or higher (overweight) if accompanied by at least one weight-related condition such as high blood pressure, Type 2 diabetes, or sleep apnea
If constipation is your primary issue, your clinician may steer you toward a different form or toward fiber first
I 2 = 73.7%) 25,27,30,31,32,35,39 , the RR in the normal BMI studies (n = 3